Palliative versus hospice care in patients with cancer: a systematic review.


Journal

BMJ supportive & palliative care
ISSN: 2045-4368
Titre abrégé: BMJ Support Palliat Care
Pays: England
ID NLM: 101565123

Informations de publication

Date de publication:
Jun 2021
Historique:
received: 10 01 2020
revised: 23 05 2020
accepted: 26 05 2020
pubmed: 19 7 2020
medline: 29 6 2021
entrez: 19 7 2020
Statut: ppublish

Résumé

Guidelines recommend an early access to specialised palliative medicine services for patients with cancer, but studies have reported a continued underuse. Palliative care facilities deliver early care, alongside antineoplastic treatments, whereas hospice care structures intervene lately, when cancer-modifying treatments stop. This review identified factors associated with early and late interventions of specialised services, by considering the type of structures studied (palliative vs hospice care). We performed a systematic review, prospectively registered on PROSPERO (ID: CRD42018110063). We searched Medline and Scopus databases for population-based studies. Two independent reviewers extracted the data and assessed the study quality using Joanna Briggs Institute critical appraisal checklists. The 51 included articles performed 67 analyses. Most were based on retrospective cohorts and US populations. The median quality scores were 19/22 for cohorts and 15/16 for cross-sectional studies. Most analyses focused on hospice care (n=37). Older patients, men, people with haematological cancer or treated in small centres had less specialised interventions. Palliative and hospice facilities addressed different populations. Older patients received less palliative care but more hospice care. Patients with high-stage tumours had more palliative care while women and patients with a low comorbidity burden received more hospice care. Main disparities concerned older patients, men and people with haematological cancer. We highlighted the challenges of early interventions for older patients and of late deliveries for men and highly comorbid patients. Additional data on non-American populations, outpatients and factors related to quality of life and socioeconomic status are needed.

Sections du résumé

BACKGROUND BACKGROUND
Guidelines recommend an early access to specialised palliative medicine services for patients with cancer, but studies have reported a continued underuse. Palliative care facilities deliver early care, alongside antineoplastic treatments, whereas hospice care structures intervene lately, when cancer-modifying treatments stop.
AIM OBJECTIVE
This review identified factors associated with early and late interventions of specialised services, by considering the type of structures studied (palliative vs hospice care).
DESIGN METHODS
We performed a systematic review, prospectively registered on PROSPERO (ID: CRD42018110063).
DATA SOURCES METHODS
We searched Medline and Scopus databases for population-based studies. Two independent reviewers extracted the data and assessed the study quality using Joanna Briggs Institute critical appraisal checklists.
RESULTS RESULTS
The 51 included articles performed 67 analyses. Most were based on retrospective cohorts and US populations. The median quality scores were 19/22 for cohorts and 15/16 for cross-sectional studies. Most analyses focused on hospice care (n=37). Older patients, men, people with haematological cancer or treated in small centres had less specialised interventions. Palliative and hospice facilities addressed different populations. Older patients received less palliative care but more hospice care. Patients with high-stage tumours had more palliative care while women and patients with a low comorbidity burden received more hospice care.
CONCLUSION CONCLUSIONS
Main disparities concerned older patients, men and people with haematological cancer. We highlighted the challenges of early interventions for older patients and of late deliveries for men and highly comorbid patients. Additional data on non-American populations, outpatients and factors related to quality of life and socioeconomic status are needed.

Identifiants

pubmed: 32680891
pii: bmjspcare-2020-002195
doi: 10.1136/bmjspcare-2020-002195
doi:

Types de publication

Comparative Study Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

188-199

Informations de copyright

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Matthieu Frasca (M)

Department of Palliative Medicine, CHU of Bordeaux, Bordeaux, Aquitaine, France matthieu.frasca@chu-bordeaux.fr.
Epicene Team, Inserm UMR 1219, Bordeaux Population Health Research Center, University of Bordeaux, Bordeaux, Aquitaine, France.

Angeline Galvin (A)

Epicene Team, Inserm UMR 1219, Bordeaux Population Health Research Center, University of Bordeaux, Bordeaux, Aquitaine, France.

Chantal Raherison (C)

Department of Pneumology, CHU of Bordeaux, Bordeaux, Aquitaine, France.

Pierre Soubeyran (P)

CIC1401, Bergonie institute, Comprehensive Cancer Center, Bordeaux, Aquitaine, France.
UMR 1218, ACTION, University of Bordeaux, Bordeaux, Aquitaine, France.

Benoît Burucoa (B)

Department of Palliative Medicine, CHU of Bordeaux, Bordeaux, Aquitaine, France.

Carine Bellera (C)

Epicene Team, Inserm UMR 1219, Bordeaux Population Health Research Center, University of Bordeaux, Bordeaux, Aquitaine, France.
CIC1401, Bergonie institute, Comprehensive Cancer Center, Bordeaux, Aquitaine, France.

Simone Mathoulin-Pelissier (S)

Epicene Team, Inserm UMR 1219, Bordeaux Population Health Research Center, University of Bordeaux, Bordeaux, Aquitaine, France.
UMR 1218, ACTION, University of Bordeaux, Bordeaux, Aquitaine, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH